Home > Healthcare > Medical Devices > Medical Supplies > Organ Preservation Solution Market

Organ Preservation Solution Market Trends

Report ID: GMI7564
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Organ Preservation Solution Market Trends

The rising prevalence of chronic diseases, such as kidney disease, liver disease, and heart failure, has led to an increased need for organ transplants. Chronic diseases can progress to end-stage conditions where organ transplantation becomes a life-saving intervention.
Therefore, increasing demand for solid organ transplantations is driving the market. For instance, according to U.S department of Health and Human Services, around 92 transplants occur in U.S. each day. Similarly, as per the Global Observatory on Donation & Transplantation (GODT) report, in 2020, nearly 39,916 organ transplants have been performed in U.S. Among these transplants, approximately 31.5% of the organs were donated by deceased donors, while 78.5% of donations were done by living donors.
Thus, increasing number of solid organ transplants will significantly drive the market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Organ preservation solution industry size reached USD 256.1 million in 2022 and is projected to expand at 6.8% CAGR from 2023-2032 driven by the rising number of organ transplantation procedures coupled with the massive healthcare investments.

University of Wisconsin (UW) segment accounted for 38.2% share of the organ preservation solution industry in 2022 and is estimated to record substantial growth through 2032 attributed to the presence of established distribution networks for facilitating its accessibility to transplantation centers.

North America organ preservation solution market was worth USD 103 million in revenue in 2022 and is anticipated to reach USD 196.5 million by 2032 driven by the well-developed and advanced healthcare infrastructure.

Some major organ preservation solution firms are Waters Medical Systems LLC, Xvivo Perfusion AB, Transmedics, Inc., Preservation Solutions, Inc., Paragonix Technologies, Inc., Organox Limited, Dr. Franz Koehler Chemie GmbH, Accord Healthcare Inc., and Shanghai Genext Medical Technology.